These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26656642)

  • 1. Cognitive Results of CANTAB Tests and Their Change Due to the First Dose of Donepezil May Predict Treatment Efficacy in Alzheimer Disease.
    Kuzmickienė J; Kaubrys G
    Med Sci Monit; 2015 Dec; 21():3887-99. PubMed ID: 26656642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Ability of Some CANTAB Battery Test Measures to Detect Cognitive Response to a Single Dose of Donepezil in Alzheimer Disease.
    Kuzmickienė J; Kaubrys G
    Med Sci Monit; 2015 Aug; 21():2572-82. PubMed ID: 26336931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial.
    Salloway S; Ferris S; Kluger A; Goldman R; Griesing T; Kumar D; Richardson S;
    Neurology; 2004 Aug; 63(4):651-7. PubMed ID: 15326237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of donepezil in patients with Alzheimer's disease: results of a global, multinational, clinical experience study.
    Boada-Rovira M; Brodaty H; Cras P; Baloyannis S; Emre M; Zhang R; Bahra R;
    Drugs Aging; 2004; 21(1):43-53. PubMed ID: 14715043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donepezil therapy in clinical practice: a randomized crossover study.
    Greenberg SM; Tennis MK; Brown LB; Gomez-Isla T; Hayden DL; Schoenfeld DA; Walsh KL; Corwin C; Daffner KR; Friedman P; Meadows ME; Sperling RA; Growdon JH
    Arch Neurol; 2000 Jan; 57(1):94-9. PubMed ID: 10634454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting.
    Wattmo C; Hansson O; Wallin AK; Londos E; Minthon L
    Dement Geriatr Cogn Disord; 2008; 26(3):203-11. PubMed ID: 18769065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease.
    Holmes C; Wilkinson D; Dean C; Vethanayagam S; Olivieri S; Langley A; Pandita-Gunawardena ND; Hogg F; Clare C; Damms J
    Neurology; 2004 Jul; 63(2):214-9. PubMed ID: 15277611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration of donepezil to the cognitive response in Alzheimer disease.
    Yang YH; Chen CH; Chou MC; Li CH; Liu CK; Chen SH
    J Clin Psychopharmacol; 2013 Jun; 33(3):351-5. PubMed ID: 23609381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donepezil therapy for neuropsychiatric symptoms in AD: methods make the message.
    Herrmann N; Knopman D
    Neurology; 2004 Jul; 63(2):200-1. PubMed ID: 15277606
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease.
    Doody RS; Dunn JK; Clark CM; Farlow M; Foster NL; Liao T; Gonzales N; Lai E; Massman P
    Dement Geriatr Cogn Disord; 2001; 12(4):295-300. PubMed ID: 11351141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of donepezil in patients with Alzheimer's disease in assisted living facilities.
    Rosenblatt A; Gao J; Mackell J; Richardson S
    Am J Alzheimers Dis Other Demen; 2010 Sep; 25(6):483-9. PubMed ID: 20558849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Ohbayashi T
    Dement Geriatr Cogn Disord; 2008; 25(5):399-407. PubMed ID: 18391486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of responders and non-responders to long-term donepezil treatment.
    Inoue J; Hoshino R; Nojima H; Ishida W; Okamoto N
    Psychogeriatrics; 2010 Jun; 10(2):53-61. PubMed ID: 20738808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cognitive-communication stimulation for Alzheimer's disease patients treated with donepezil.
    Chapman SB; Weiner MF; Rackley A; Hynan LS; Zientz J
    J Speech Lang Hear Res; 2004 Oct; 47(5):1149-63. PubMed ID: 15603468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer's disease.
    Tariot P; Salloway S; Yardley J; Mackell J; Moline M
    BMC Res Notes; 2012 Jun; 5():283. PubMed ID: 22681723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: implications for early diagnosis and treatment.
    Molinuevo JL; Berthier ML; Rami L
    Arch Gerontol Geriatr; 2011; 52(1):18-22. PubMed ID: 19948364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S
    Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional donepezil treatment for patients with geriatric depression who exhibit cognitive deficit during treatment for depression.
    Inoue J; Hoshino R; Nojima H; Ishida W; Okamoto N
    Psychogeriatrics; 2016 Jan; 16(1):54-61. PubMed ID: 25919986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive predictors of donepezil therapy response in Alzheimer disease.
    Saumier D; Murtha S; Bergman H; Phillips N; Whitehead V; Chertkow H
    Dement Geriatr Cogn Disord; 2007; 24(1):28-35. PubMed ID: 17495473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPECT-identified neuroanatomical predictor of the cognitive effects of donepezil treatment in patients with Alzheimer's disease.
    Hongo J; Nakaaki S; Shinagawa Y; Murata Y; Sato J; Tatsumi H; Tohyama J; Soma T; Iidaka T; Fukui T; Mimura M; Furukawa TA
    Dement Geriatr Cogn Disord; 2008; 26(6):556-66. PubMed ID: 19066429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.